PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 95 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $264,866 | -42.7% | 37,096 | -32.3% | 0.00% | 0.0% |
| Q2 2022 | $462,000 | +40.0% | 54,769 | +124.9% | 0.00% | 0.0% |
| Q1 2022 | $330,000 | -47.8% | 24,352 | -24.3% | 0.00% | 0.0% |
| Q4 2021 | $632,000 | -37.2% | 32,165 | +8.2% | 0.00% | -80.0% |
| Q2 2021 | $1,007,000 | -76.5% | 29,731 | -73.9% | 0.01% | -75.0% |
| Q1 2021 | $4,278,000 | +8.6% | 113,885 | -4.0% | 0.02% | -4.8% |
| Q4 2020 | $3,941,000 | – | 118,649 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |